Li M, Yu XQ. Genetic determinants of IgA nephropathy: Eastern perspective. Semin Nephrol. 2018;38(5):455–60. https://doi.org/10.1016/j.semnephrol.2018.05.015.
Article CAS PubMed Google Scholar
Willey CJ, Coppo R, Schaefer F, Mizerska-Wasiak M, Mathur M, Schultz MJ. The incidence and prevalence of IgA nephropathy in Europe. Nephrol Dial Transpl. 2023;38(10):2340–9. https://doi.org/10.1093/ndt/gfad082.
Paoletti E, De Nicola L, Gabbai FB, Chiodini P, Ravera M, Pieracci L, et al. Associations of left ventricular hypertrophy and geometry with adverse outcomes in patients with CKD and hypertension. Clin J Am Soc Nephro. 2016;11(2):271–9. https://doi.org/10.2215/CJN.06980615.
Ahmad MI, Mujtaba M, Anees MA, Li Y, Soliman EZ. Interrelation between electrocardiographic left atrial abnormality, left ventricular hypertrophy, and mortality in participants with hypertension. Am J Cardiol. 2019;124(6):886–91. https://doi.org/10.1016/j.amjcard.2019.06.003.
Wang C, Bao X, Du G, Wang Y, Chen K, Shen M, et al. Effects of insulin resistance on left ventricular hypertrophy in patients with CKD stage 1–3. Int Urol Nephrol. 2014;46(8):1609–17. https://doi.org/10.1007/s11255-014-0720-3.
Article CAS PubMed PubMed Central Google Scholar
Liao MT, Sung CC, Hung KC, Wu CC, Lo L, Lu KC. Insulin resistance in patients with chronic kidney disease. J Biomed Biotechnol. 2012;2012: 691369. https://doi.org/10.1155/2012/691369.
Article CAS PubMed PubMed Central Google Scholar
Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, et al. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE. 2016;11(3): e0149731. https://doi.org/10.1371/journal.pone.0149731.
Article CAS PubMed PubMed Central Google Scholar
Lee J, Kim B, Kim W, Ahn C, Choi HY, Kim JG, et al. Lipid indices as simple and clinically useful surrogate markers for insulin resistance in the U.S. population. Sci Rep-Uk. 2021;11(1):2366. https://doi.org/10.1038/s41598-021-82053-2.
Kianu PB, Nkodila NA, Nzundu TA, Kokusa ZR, Limbole BE, Kintoki VE, et al. Insulin resistance-related differences in the relationship between left ventricular hypertrophy and cardiorespiratory fitness in hypertensive Black sub-Saharan Africans. Am J Cardiovasc Dis. 2021;11(5):587–600.
Huo RR, Liao Q, Zhai L, You XM, Zuo YL. Interacting and joint effects of triglyceride-glucose index (TyG) and body mass index on stroke risk and the mediating role of TyG in middle-aged and older Chinese adults: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23(1):30. https://doi.org/10.1186/s12933-024-02122-4.
Article CAS PubMed PubMed Central Google Scholar
Yang X, Li K, Wen J, Yang C, Li Y, Xu G, et al. Association of the triglyceride glucose-body mass index with the extent of coronary artery disease in patients with acute coronary syndromes. Cardiovasc Diabetol. 2024;23(1):24. https://doi.org/10.1186/s12933-024-02124-2.
Article CAS PubMed PubMed Central Google Scholar
Li F, Wang Y, Shi B, Sun S, Wang S, Pang S, et al. Association between the cumulative average triglyceride glucose-body mass index and cardiovascular disease incidence among the middle-aged and older population: a prospective nationwide cohort study in China. Cardiovasc Diabetol. 2024;23(1):16. https://doi.org/10.1186/s12933-023-02114-w.
Article CAS PubMed PubMed Central Google Scholar
Zhai Y, Fu H, Li Y, Li S, Zhang W, Yue J, et al. Relationship between four insulin resistance surrogates and left ventricular hypertrophy among hypertensive adults: a case-control study. Endocr Connect. 2024. https://doi.org/10.1530/EC-23-0476.
Article PubMed PubMed Central Google Scholar
Shen FC, Lin HY, Tsai WC, Kuo IC, Chen YK, Chao YL, et al. Non-insulin-based insulin resistance indices for predicting all-cause mortality and renal outcomes in patients with stage 1–4 chronic kidney disease: another paradox. Front Nutr. 2023;10:1136284. https://doi.org/10.3389/fnut.2023.1136284.
Article CAS PubMed PubMed Central Google Scholar
Zhan C, Peng Y, Ye H, Diao X, Yi C, Guo Q, et al. Triglyceride glucose-body mass index and cardiovascular mortality in patients undergoing peritoneal dialysis: a retrospective cohort study. Lipids Health Dis. 2023;22(1):143. https://doi.org/10.1186/s12944-023-01892-2.
Article CAS PubMed PubMed Central Google Scholar
Schiller NB, Shah PM, Crawford M, Demaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiog. 1989;2(5):358–67. https://doi.org/10.1016/S0894-7317(89)80014-8.
Cai S, Zhu T, Ding Y, Cheng B, Zhang A, Bao Q, et al. The relationship between the weight-adjusted-waist index and left ventricular hypertrophy in Chinese hypertension adults. Hypertens Res. 2023;46(1):253–60. https://doi.org/10.1038/s41440-022-01075-z.
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiog. 2015;28(1):1-39.e14. https://doi.org/10.1016/j.echo.2014.10.003.
de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol. 1995;25(5):1056–62. https://doi.org/10.1016/0735-1097(94)00540-7.
Viwatrangkul P, Lawanwisut S, Leekhaphan P, Prasart-Intara T, Phiensuparp P, Prakiatpongsa S, et al. Prevalence and associated factors of electrocardiographic left ventricular hypertrophy in a rural community, central Thailand. Sci Rep-Uk. 2021. https://doi.org/10.1038/s41598-021-86693-2.
Baldo MP, Gonçalves MA, Capingana DP, Magalhães P, Da Silva ABT, Mill JG. Prevalence and clinical correlates of left ventricular hypertrophy in Black Africans. High Blood Press Car. 2018;25(3):283–9. https://doi.org/10.1007/s40292-018-0267-y.
Cuspidi C, Gherbesi E, Sala C, Tadic M. Sex, gender, and subclinical hypertensiveorgan damage-heart. J Hum Hypertens. 2023;37(8):626–33. https://doi.org/10.1038/s41371-022-00750-5.
Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, et al. Gender differences in left ventricular structure and function during antihypertensive treatment: the losartan intervention for endpoint reduction in hypertension study. Hypertension (Dallas, Tex 1979). 2008;51(4):1109–14. https://doi.org/10.1161/HYPERTENSIONAHA.107.107474.
Article CAS PubMed Google Scholar
Cai A, Liu L, Zhou D, Tang S, Zhou Y, Feng Y. Influences of achieved SBP on age and sex-related left ventricular structural alteration in community hypertensive populations. J Hypertens. 2022;40(6):1170–8. https://doi.org/10.1097/HJH.0000000000003127.
Article CAS PubMed Google Scholar
de Simone G, Mancusi C, Izzo R, Losi MA, Aldo FL. Obesity and hypertensive heart disease: focus on body composition and sex differences. Diabetol Metab Syndr. 2016;8:79. https://doi.org/10.1186/s13098-016-0193-x.
Article CAS PubMed PubMed Central Google Scholar
Nista F, Gatto F, Albertelli M, Musso N. Sodium intake and target organ damage in hypertension-an update about the role of a real villain. Int J Env Res Pub He. 2020. https://doi.org/10.3390/ijerph17082811.
van der Westhuizen B, Schutte AE, Gafane-Matemane LF, Kruger R. Left ventricular mass independently associates with 24-hour sodium excretion in young masked hypertensive adults: the African-PREDICT study. Int J Cardiol. 2019;276:218–23. https://doi.org/10.1016/j.ijcard.2018.11.116.
Kong YW, Baqar S, Jerums G, Ekinci EI. Sodium and its role in cardiovascular disease—the debate continues. Front Endocrinol. 2016;7:164. https://doi.org/10.3389/fendo.2016.00164.
Rodriguez CJ, Bibbins-Domingo K, Jin Z, Daviglus ML, Goff DJ, Jacobs DJ. Association of sodium and potassium intake with left ventricular mass: coronary artery risk development in young adults. Hypertension. 2011;58(3):410–6.
Comments (0)